No registrations found.
ID
Source
Health condition
Breast cancer
Shared decision making
Implementation
Decision aid
Patient communication
Borstkanker
Gezamelijk beslissen
Keuzehulpen
Implementatie
Patient communicatie
Sponsors and support
Intervention
Outcome measures
Primary outcome
With respect to our hypotheses on frequency of registering indication for a patient decision aid in the Multidisciplinary Board, for handing out and actually logging in, and assuming that that we can include 150 patients in total (5 hospitals, 30 patients per hospital), we expect that:
- in 120 patients the indication for the decision aid is registered in the Multidisciplinary tumor board, i.e. in 80%, with a 95% CI of 74-86%.
- in 105 patients the personalized decision aid will be handed out, i.e. in 70% with a 95% CI of 63-77%.
- 90 patients will actually log in to the patient decision aid, i.e. 60% with a 95% CI of 53-67%.
Secondary outcome
Evaluation experiences professionals of applying the Shared Decision Making and the use of the decision aid
Background summary
Rationale: Practice variations in treatment of early-stage breast cancer should be determined by the preferences of well-informed patients. There is, however, substantial practice variation in type of surgery in breast cancer between Dutch hospitals. Involving patients in the decision making process is seen as an important strategy to reduce unwarranted variation in preference-sensitive care. In an earlier study, we developed a personalized patient decision aid, which was pilot tested in 4 hospitals. Based upon this pilot test, we adapted the implementation strategy. Currently, the decision aid is being implemented in the hospitals in the OncoZON region, and in the hospitals that had participated in the pilot study.
Objectives: The main aim of the current study is to further investigate implementation challenges, by investigating the actual implementation rate at several levels, by investigating barrieres and facilitators for implementation, and by investigating patient-experiences on shared decision making.
Study design: This study concerns an observational study, a prospective process evaluation of the implementation of the decision aid.
Study population: Patients with newly diagnosed breast cancer, stage I or II who are eligible for breast conserving therapy or mastectomy can be included. We expect that 5 hospitals will each include 30 patients in a period of 6 months. In addition, in each hospital, all breast surgeons, medical oncologists, radiation oncologists, reconstructive surgeons, nurse practitioners and nurses taking part in the education and decision-making process are invited to participate in implementation of SDM.
Study design
Audits and interviews: immediately after implementation
Patient questionnaires: during implementation.
Intervention
The intervention consists of offering patients a personalized patient decision aid.
W. Savelberg
Maastricht 6200 MD
The Netherlands
043-3882336
wilma.savelberg@maastrichtuniversity.nl
W. Savelberg
Maastricht 6200 MD
The Netherlands
043-3882336
wilma.savelberg@maastrichtuniversity.nl
Inclusion criteria
Patients with newly diagnosed breast cancer, stage I or II who are eligible for breast conserving therapy or mastectomy
Exclusion criteria
Not understanding the Dutch language
Design
Recruitment
Followed up by the following (possibly more current) registration
No registrations found.
Other (possibly less up-to-date) registrations in this register
No registrations found.
In other registers
| Register | ID |
|---|---|
| NTR-new | NL5614 |
| NTR-old | NTR5721 |
| Other | KWf Ad6 shared decision making : 2014-7024 |